Ozelle unveils O-Cyte 1 hematology analyzer at MEDICA 2026
Ozelle has introduced the O-Cyte 1, an automated analyzer that bridges the gap between routine blood counts and cellular imaging.

Ozelle debuted its O-Cyte 1 analyzer at the MEDICA 2026 trade fair in Düsseldorf. The hardware is designed to automate the examination of blood samples when a standard complete blood count (CBC) identifies potential abnormalities, facilitating a more streamlined workflow for laboratory technicians.
The system utilizes automated cellular imaging to provide detailed context alongside numeric blood counts. This approach aims to reduce the reliance on manual microscopy, which traditionally serves as the follow-up step for verifying flagged samples in clinical hematology.
The diagnostics industry is increasingly shifting toward integrated platforms that combine analytical data with visual evidence to support clinical decision-making. By automating the transition from screening to verification, the O-Cyte 1 targets efficiency bottlenecks in hospital laboratories.
The presentation at MEDICA provides the industry with a first look at the technology, which is slated for integration into professional hematology diagnostic environments.